Hayakawa M, (2018) Management of disseminated intravascular coagulation: current insights on antithrombin and thrombomodulin treatments. Open Access Emerg Med 10: 25-29
Hayakawa M, Ono K, (2018) A summary of the Japan septic disseminated intravascular coagulation study. Acute Med Surg 5: 123-128
Gando S, Mayumi T, Ukai T. Activated protein C plays no major roles in the inhibition of coagulation or increased fibrinolysis in acute coagulopathy of trauma-shock: a systematic review. Thromb J 2018;16:13.
Gando S, Mayumi T, Ukai T. The roles of activated protein C in experimental trauma models. Chin J Traumatol. 2018;21:311-315
原著(英文)
Hayakawa M, Yamakawa K, Kudo D, Ono K, (2018) Optimal Antithrombin Activity Threshold for Initiating Antithrombin Supplementation in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Multicenter Retrospective Observational Study. Clin Appl Thromb Hemost 24: 874-883
Hayakawa M, Yamakawa K, Saito S, Uchino S, Kudo D, Iizuka Y, Sanui M, Takimoto K, Mayumi T, (2018) Nationwide registry of sepsis patients in Japan focused on disseminated intravascular coagulation 2011-2013. Sci Data 5: 180243
Iba T, Arakawa M, Di Nisio M, Gando S, Anan H, Sato K, Ueki Y, Levy JH, Thachil J, (2018) Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality. J Intensive Care Med: 885066618773679
Kitamura T, Iwami T, Atsumi T, Endo T, Kanna T, Kuroda Y, Sakurai A, Tasaki O, Tahara Y, Tsuruta R, Tomio J, Nakata K, Nachi S, Hase M, Hayakawa M, Hiruma T, Hiasa K, Muguruma T, Yano T, Shimazu T, Morimura N, (2018) The profile of Japanese Association for Acute Medicine – out-of-hospital cardiac arrest registry in 2014-2015. Acute Med Surg 5: 249-258
Kudo D, Hayakawa M, Ono K, Yamakawa K, (2018) Impact of non-anticoagulant therapy on patients with sepsis-induced disseminated intravascular coagulation: A multicenter, case-control study. Thromb Res 163: 22-29
Kumano O, Ieko M, Komiyama Y, Naito S, Yoshida M, Takahashi N, Ohmura K, Hayasaki J, Hayakawa M, (2018) Basic Evaluation of the Newly Developed “Lias Auto P-FDP” Assay and the Influence of Plasmin-alpha2 Plasmin Inhibitor Complex Values on Discrepancy in the Comparison with “Lias Auto D-Dimer Neo” Assay. Clin Lab 64: 433-442
Kushimoto S, Gando S, Ogura H, Umemura Y, Saitoh D, Mayumi T, Fujishima S, Abe T, Shiraishi A, Ikeda H, Kotani J, Miki Y, Shiraishi SI, Suzuki K, Suzuki Y, Takeyama N, Takuma K, Tsuruta R, Yamaguchi Y, Yamashita N, Aikawa N, (2018) Complementary Role of Hypothermia Identification to the Quick Sequential Organ Failure Assessment Score in Predicting Patients With Sepsis at High Risk of Mortality: A Retrospective Analysis From a Multicenter, Observational Study. J Intensive Care Med: 885066618761637
Nakashima T, Miyamoto K, Shimokawa T, Kato S, Hayakawa M, (2018) The Association Between Sequential Organ Failure Assessment Scores and Mortality in Patients With Sepsis During the First Week: The JSEPTIC DIC Study. J Intensive Care Med: 885066618775959
Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, Imaizumi H, Inoue S, Kakihana Y, Kotani J, Kushimoto S, Masuda Y, Matsuda N, Matsushima A, Nakada TA, Nakagawa S, Nunomiya S, Sadahiro T, Shime N, Yatabe T, Hara Y, Hayashida K, Kondo Y, Sumi Y, Yasuda H, Aoyama K, Azuhata T, Doi K, Doi M, Fujimura N, Fuke R, Fukuda T, Goto K, Hasegawa R, Hashimoto S, Hatakeyama J, Hayakawa M, Hifumi T, Higashibeppu N, Hirai K, Hirose T, Ide K, Kaizuka Y, Kan’o T, Kawasaki T, Kuroda H, Matsuda A, Matsumoto S, Nagae M, Onodera M, Ohnuma T, Oshima K, Saito N, Sakamoto S, Sakuraya M, Sasano M, Sato N, Sawamura A, Shimizu K, Shirai K, Takei T, Takeuchi M, Takimoto K, Taniguchi T, Tatsumi H, Tsuruta R, Yama N, Yamakawa K, Yamashita C, Yamashita K, Yoshida T, Tanaka H, Oda S, (2018) The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). Acute Med Surg 5: 3-89
Nishida O, Ogura H, Egi M, Fujishima S, Hayashi Y, Iba T, Imaizumi H, Inoue S, Kakihana Y, Kotani J, Kushimoto S, Masuda Y, Matsuda N, Matsushima A, Nakada TA, Nakagawa S, Nunomiya S, Sadahiro T, Shime N, Yatabe T, Hara Y, Hayashida K, Kondo Y, Sumi Y, Yasuda H, Aoyama K, Azuhata T, Doi K, Doi M, Fujimura N, Fuke R, Fukuda T, Goto K, Hasegawa R, Hashimoto S, Hatakeyama J, Hayakawa M, Hifumi T, Higashibeppu N, Hirai K, Hirose T, Ide K, Kaizuka Y, Kan’o T, Kawasaki T, Kuroda H, Matsuda A, Matsumoto S, Nagae M, Onodera M, Ohnuma T, Oshima K, Saito N, Sakamoto S, Sakuraya M, Sasano M, Sato N, Sawamura A, Shimizu K, Shirai K, Takei T, Takeuchi M, Takimoto K, Taniguchi T, Tatsumi H, Tsuruta R, Yama N, Yamakawa K, Yamashita C, Yamashita K, Yoshida T, Tanaka H, Oda S, (2018) The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016). J Intensive Care 6: 7
Saito S, Uchino S, Hayakawa M, Yamakawa K, Kudo D, Iizuka Y, Sanui M, Takimoto K, Mayumi T, Sasabuchi Y, (2018) Epidemiology of disseminated intravascular coagulation in sepsis and validation of scoring systems. J Crit Care 50: 23-30
Umemura Y, Yamakawa K, Hayakawa M, Hamasaki T, Fujimi S, (2018) Screening itself for disseminated intravascular coagulation may reduce mortality in sepsis: A nationwide multicenter registry in Japan. Thromb Res 161: 60-66
Umemura Y, Yamakawa K, Hayakawa M, Kudo D, Fujimi S, (2018) Concomitant Versus Individual Administration of Antithrombin and Thrombomodulin for Sepsis-Induced Disseminated Intravascular Coagulation: A Nationwide Japanese Registry Study. Clin Appl Thromb Hemost 24: 734-740
Yamakawa K, Yoshimura J, Ito T, Hayakawa M, Hamasaki T, Fujimi S, (2019) External Validation of the Two Newly Proposed Criteria for Assessing Coagulopathy in Sepsis. Thromb Haemost 119: 203-212
Endo S, Shimazaki R; Antithrombin Gamma Study Group. An open-label, randomized, phase 3 study of the efficacy and safety of antithrombin gamma in patients with sepsis-induced disseminated intravascular coagulation syndrome. J Intensive Care 2018;6:75.
Abe T, Ogura H, Shiraishi A, Kushimoto S, Saitoh D, Fujishima S, Mayumi T, Shiino Y, Nakada TA, Tarui T, Hifumi T, Otomo Y, Okamoto K, Umemura Y, Kotani J, Sakamoto Y, Sasaki J, Shiraishi SI, Takuma K, Tsuruta R, Hagiwara A, Yamakawa K, Masuno T, Takeyama N, Yamashita N, Ikeda H, Ueyama M, Fujimi S, Gando S; JAAM FORECAST group. Characteristics, management, and in-hospital mortality among patients with severe sepsis in intensive care units in Japan: the FORECAST study. Crit Care. 2018;22:322
国際学会 特別講演(基調講演・招待講演・教育講演・一般講演・教育セミナー)
Gando S. (invited lecture) Disseminated intravascular coagulation in trauma and terminology standardization. ISTH SSC 2018 Meeting, July 18-21, 2018, Dublin
Maekawa K, Hayakawa M, Yoshida T, Itagaki Y, Tsuchida T, Tomita A, Honma Y, Mizugaki A, Murakami H, Oyasu T, Saito T, Katabami K, Wada T, Sageshima H, Sawamura A. Circadian variation of outcomes in out-of-hospital cardiac arrest of cardiac etiology 38th ISICEM, March 20-23, 2018, Brussels
Wada T, Nakahori Y, Laura A. Cahill, Jennifer P. Nguyen, Fei Guo, Joshua W. Keegan, Anupamaa Seshadri and James A. Lederer. “TOLL-LIKE RECEPTOR 9 TARGETED THERAPY RESTORES CELLULAR ANTI-MICROBIAL IMMUNE FUNCTION AFTER TRAUMATIC INJURY” The 41th Annual Conference on Shock, June 9 – 12, 2018, Scottsdale, Arizona
Saito T, Hayakawa M, Katabami K, Sageshima H, Wada T, Maekawa K, Sawamura A, Gando S. HYPERFIBRINOLYSIS IN PATIENTS WITH OUT-OF-HOSPITAL CARDIAC ARREST:THE ASSOCIATION OF ROTATIONAL THROMBOELASTOMETRY WITH CONVENTIONAL FIBRINOLYSIS MARKERS The 41th Annual Conference on Shock, June 9 – 12, 2018, Scottsdale, Arizona
Maekawa K, Hayakawa M, Yoshida T, Itagaki Y, Tsuchida T, Kawahara S, Tomita A, Mizugaki A, Murakami H, Oyasu T, Saito T, Katabami K, Wada T, Sawamura A. Cardiac arrest and post resuscitation care, Poster corner, 22.10.2018 0312 – Chest compression-only vs conventional CPR by laypersons for unwitnessed out-of-hospital cardiac arrest ESICM 31st Annual Congress Paris, October20-24,2018, Paris
Tsuchida T, Wada T, Gando S. Cardiac arrest – Aspects before and after ROSC, Poster corner, 22.10.2018 0445 – Dynamic changes in coagulation and fibrinolysis during percutaneous cardiopulmonary support in patients after out-of-hospital cardiac arrest ESICM 31st Annual Congress Paris, October20-24, 2018, Paris
Yoshida T, Maekawa K, Takahashi Y, Matsumoto H, Itagaki Y, Tsuchida T, Sadamoto Y, Tomita A, Kawahara S, Mizugaki A, Murakami H, Oyasu T, Saito T, Katabami K, Wada T, Hayakawa M, Sawamura A. Cardiac arrest management, Rome, 24.10.2018 11:10-11:25 1009 – Survival and neurological outcome in the elderly after out-of-hospital cardiac arrest ESICM 31st Annual Congress Paris, October20-24,2018, Paris
Katabami K, Hayakawa M. Scoring for sepsis identification, Poster corner, 24.10.2018 1088 – Comparison of sepsis biomarkers in critical patients upon admission to the emergency room ESICM 31st Annual Congress Paris, October20-24,2018, Paris
(座長)早川峰司 (特別プログラム)学術推進委員会(SPC)シンポジウム4「血栓症病態への好中球の関与を議論する―Discuss how neutrophils contribute to the pathogenesis of thrombotic diseases―」4演題 第40回日本血栓止血学会学術集会 2018年6月 札幌
早川峰司:Current Status and Significance of Fibrinogen Concentrate Administration in Emergency and Critical Care 第32回Transfusion Medicine Conference 2018年1月 神奈川
和田剛志 Mitchell Fink President Travel Award The 41th Annual Conference on Shock (U.S.A.) ‘TOLL-LIKE RECEPTOR 9 TARGETED THERAPY RESTORES CELLULAR ANTI-MICROBIAL IMMUNE FUNCTION AFTER TRAUMATIC INJURY.’ 2018年6月